CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

The drugmaker’s shares did not react on Friday afternoon. CVS Caremark said in its statement that any attempt to curtail pharmacy benefit managers’ ability to negotiate drug prices will only benefit ...

Both CVS and Walgreens said in written statements that they respect their employees’ right to unionize. The United Food and ...

The Arkansas Insurance Department will require pharmacy benefit managers (PBMs) to include dispensing fees in their ...

Kansas City pharmacists walked off the job last September to protest working conditions and brought widespread attention to ...

A year ago this week, 27 pharmacists walked off their jobs in and around Kansas City to protest understaffing, low technician ...